SUPERVISOR WIENER’S STATEMENT ON KAISER’S REVERSAL ON ITS POLICY TO DRAMATICALLY INCREASE COST OF HIV DRUGS FOR PATIENTS
Kaiser announced today that it will be reversing a recent policy change to reclassify HIV medication as “specialty drugs,” which dramatically raised costs for patients
San Francisco, CA – Today, Supervisor Wiener issued the following statement on Kaiser Permanente’s reversal of its decision to dramatically increase the cost of HIV drugs for patients, and its return to the previous system where patients pay a low, affordable co-pay for HIV medication:
“Over the course of the last week, I expressed serious concern to Kaiser about this policy change that would have dramatically affected access to care for HIV-positive patients. Throughout the week, I heard an outpouring of concern from the community about the effects of these cost increases. Yesterday at a meeting in my office, Kaiser informed me that these cost increases will no longer be taking place, and that patients will be returned to the previous system of paying manageable co-pays for these life dependent medications. Kaiser also informed me that it will be reimbursing patients for any increased co-payments that patients made. I want to thank Kaiser for its recognition of the dramatic impact these drug cost increases would have had on patients, and for taking swift action to ensure the health of people living with HIV.”
Last week, after learning of these cost increases. Supervisor Wiener announced he would be calling for an oversight hearing on the drug cost increases and working with Kaiser to find solutions to reverse the trend of increasing drug costs.
According to a report published in the Bay Area Reporter, Kaiser began requiring people living with HIV/AIDS to pay a significant percentage of the cost HIV medication, instead of a fixed co-pay amount. Last year, the copay amounts for generic drugs was $35, and the copay for brand name drugs was $50. While these copays remain for most drugs, Kaiser created a tier of drugs called “specialty drugs” where patients also pay 20% of the total price of the drugs. This is part of a growing trend for insurance companies to move certain drugs, including HIV drugs, to a specialty tier. The result is that patients may have to pay hundreds of dollars a month – even as high as $600 or $900 a month -- for their HIV medication.
Access to HIV medication is a core part of San Francisco’s “Getting to Zero” strategy – zero new infections, zero HIV deaths, and zero stigma. Access to HIV medication for HIV-positive people is critical because that access keeps these patients healthy and suppresses their viral load. People with suppressed viral loads are much less likely to transmit the virus to other people.
According to a report published in the Bay Area Reporter, Kaiser Permanente recently began requiring people living with HIV/AIDS to pay a percentage of the cost their drugs, instead of a copay amount. Last year, the copay amounts for generic drugs was $35, and the copay for brand name drugs was $50. While these copays remain for most drugs, Kaiser created a tier of drugs called “specialty drugs” where patients also pay 20% of the cost of those drugs. This is part of a growing trend for insurance companies to move certain drugs, including HIV drugs, to a specialty tier. The result is that patients may have to pay hundreds of dollars a month for their HIV medication. I will be holding an oversight hearing on this issue to address this decision and how it impacts our residents living with HIV, as well as to explore solutions that will reverse this trend of increasing medical costs.
You can read coverage of the issue in the Bay Area Reporter here.
The Board of Supervisors unanimously passed my legislation to adopt the Urban Forest Master Plan. The Plan, which establishes polices and strategies to manage and grow the city’s street tree population, makes a key finding that the city’s current program of transferring street tree maintenance responsibility to property owners is a short-sighted solution and ultimately to the long-term detriment of street trees and the city as a whole. This legislation is a key step in fixing our broken street tree system and ensuring the long term sustainability of our urban forest.Read more
The current spread of measles has made clear the dangers of allowing children to go unvaccinated. There is no scientific basis for not vaccinating our children, and the risk we take on by allowing this to happen is a public health problem. I'm supportive of Senator Richard Pan's proposed legislation to remove the Personal Belief Exemption from the vaccination requirement, and I will be authoring a resolution at the Board of Supervisors in support of this legislation. We should be moving forward, not backwards, in our efforts to protect our children from the spread of disease.Read more
Recently, I sat down for an interview with the San Francisco Business Times to talk about housing, transportation and other issues affecting San Francisco. You can read the Q&A at the San Francisco Business Time website.
Ballot measures play a critical role in our lawmaking process. Voters set policy on many issues of significance to our city's future, from housing to transportation to civil rights. Whether ballot measures are initiated by residents collecting signatures or by elected officials, our process should produce well-written measures that are vetted by the public through a transparent process.
I recently announced that I am working with our city attorney to draft a ballot measure reform proposal for submission to the voters that will increase transparency and public participation, stabilize wild fluctuations in the number of signatures required and provide backers with tools to improve their measures based on public feedback.Read more
Next week, we're moving forward with groundbreaking anti-discrimination legislation to protect LGBT seniors residing in long-term-care facilities in San Francisco -- the first legislation of its kind in the nation.
This proposal is a strong first step to ensure that our LGBT elders -- a growing population that built this community and brought us where we are today -- are treated with the dignity and respect they deserve. One of the key findings of the LGBT Aging Task Force, which made policy recommendations last year, was that LGBT seniors residing in these facilities are at increased risk of discrimination, stigmatization, and even being pushed back into the closet. While many senior facilities do excellent and culturally competent work with LGBT seniors, other do not. I look forward to our continuing conversation and work around the needs of seniors.Read more
San Francisco, CA—The San Francisco County Transportation Authority Board today elected Commissioner Scott Wiener chair for 2015. Created by voters in 1989, the Transportation Authority administers the ½ cent transportation sales tax and serves as congestion management agency for San Francisco. The agency is celebrating its 25th anniversary this year.Read more
For the past several years, we've been engaged in a dialogue with the Fire Department about how best to embrace two critical public safety needs: fire safety and street safety. The Fire Department has advocated for wider streets, given the size of its trucks, whereas wider streets are more dangerous for all users, leading to increased speeds, more accidents, and more severe accidents. We want our fire trucks to be able to get to fires and other emergencies quickly, and, in fact, our department does an outstanding and heroic job doing just that. We also want our streets to be safe -- we have way too many accidents that injure or kill pedestrians, cyclists, and drivers -- and good street design is essential for safe streets. If the Fire Department is concerned about its trucks ability to maneuver on San Francisco's many, many narrow streets, the Department needs to evaluate how it can improve its trucks' ability to maneuver those streets.Read more
Today the San Francisco Chronicle ran a nice profile of me. It basically says I'm boring and nerdy but work hard. I'll take that.Read more